Below is a list of the studies we are currently recruiting for. If you would like to participate in any of these please follow the link below each study to apply.
This study is looking for mildly asthmatic children aged 5-15. The aim is to see if taking a preventer inhaler only when needed is as effective as taking it every day.
To find out more, visit the Study’s website – asymptomatic-trial.org.uk
To participate, complete this form: Expression of Interest Form (lctc.org.uk)
This study is trialling using a medical device to improve ADHD symptoms.
To participate email attens@soton.ac.uk or call 07923 881937.
This trial is looking to see if Amitriptyline can prevent long term pain from the virus Shingles.
To find out more visit the study’s website – https://athena-study.bristol.ac.uk/
To participate, email: athena-study@bristol.ac.uk.
This trial is looking for adult patients with leg cellulitis and aims to evaluate the optimal use of flucloxacillin in treatment.
To find out more visit the study’s website – https://www.southampton.ac.uk/ctu/coat-study.page
To participate, email: coat@soton.ac.uk.
Living Well Partnership is taking part in the CMVibe study which aims to evaluate the
safety and immune response of an investigational vaccine, which aims to prevent
cytomegalovirus (CMV) infection in children between 9 to 15 years of age.
Living Well Partnership is working with our research technology partner uMed to invite
patients to this study. If you meet the study criteria, you may receive a text message, email
or letter asking whether you would like to take part. Participation is entirely voluntary and you
can opt out at any time.
If you have any questions about this study please contact the uMed nurse support team at
patientsupport@umed.io
This trial is looking for patients with atrial fibrillation to try a newer anticoagulant, blood thinning tablets, to prevent serious long-term complications.
To find out more visit the study’s website – birmingham.ac.uk/research/cardiovascular-sciences/research/dare2think/patients-public/index.aspx
This study is looking to see if a novel way of testing for asthma FeNO can actually be used to monitor patient’s progression and guide their treatment.
To find out more, visit the study’s website – phctrials.ox.ac.uk/studies/define
To participate, email: define@phc.ox.ac.uk
Join Dementia Research is a nationwide service that allows people to register their
interest in taking part in dementia research studies. People with dementia, their carers or
those that provide support and anyone over 18 interested in research can sign up.
To find out more, visit the study’s website: Join dementia research – register your interest in dementia research : Home (nihr.ac.uk)
To participate, complete this form: Register for Join Dementia Research (nihr.ac.uk)
This trial seeks children aged 1 to 17 who have been prescribed 7 or more reliever (blue) inhalers in the past year. Eligible participants can book an enhanced asthma/wheeze check-up as part of a project by University Hospitals Southampton NHS Foundation Trust.
To find out more, visit the study’s website: For participants – PARC (soton.ac.uk)
To participate, complete this form https://bit.ly/PARC-Expression-of-Interest
A randomised controlled trial to explore knowledge, views and behaviours surrounding inhaler selection and whether the carbon footprint of inhalers is important to patients.
To find out more, visit the study’s website: Reduce Carbon Study.
This trial is testing a new inhaler treatment among patients age up to 18 years with mild asthma to see if a combined inhaler works better at relieving symptoms. This approach follows recommendations from the Global Initiative for Asthma, which suggests replacing the standard reliever inhaler with this combination to provide a preventive dose alongside symptom relief.
To find out more, visit the study’s website: Information for Participants – The University of Nottingham (relieftrial.ac.uk)
To participate, complete this form https://rc.nctu.ac.uk/surveys/?s=CMNEY73Y3JLCPTJK
This study aims to explore whether sounds, such as breathing, speaking and coughing, can be used to predict whether someone with a cough caused by infection is likely to get better or worse. An app, Breath Tracker, will be used to record your voice.
To find out more visit the study’s website: RELOAD
To participate, read this information sheet: RELOADPISV3.1.pdf (southampton.ac.uk)
uMed support LWP by inviting our patients to various studies. The studies will be signed off by the Practice as relevant to the patient’s health circumstances.
Living Well Partnership is taking part in the Von Willebrand Disease study which aims to
assess the total and treated bleeding event rate in participants with von Willebrand Disease
(VWD) on standard of care prophylaxis or on demand treatment, to identify potential
participants and establish a historical comparator for future clinical studies.
This study is recruiting male and female participants between the age of 18 to 65 years of
age with a confirmed diagnosis of Type 1 Von Willebrand Disease.
Living Well Partnership is working with our research technology partner uMed to invite
patients to this study. If you meet the study criteria, you may receive a text message, email
or letter asking whether you would like to take part. Participation is entirely voluntary and you
can opt out at any time.
If you have any questions about this study please contact the uMed nurse support team at
patientsupport@umed.io